The Tisch Cancer Institute at Mount Sinai is a leader in translating clinical research into cancer immunotherapies for patients. PICI researcher Nina Bhardwaj, MD, PhD, at Mount Sinai is an expert who contributes foundational insights in understanding patient responses to immunotherapy treatments. She closely examines immune behavior to test and develop cancer-curing vaccines. Bhardwaj is instrumental on several PICI research projects and clinical trials, with a focus on prostate and pancreatic cancers. Nina Bhardwaj, MD, PhD | Investigator Related Research Focus Tumor Antigen Discovery: Targeting Cancer Research Project Tumor Neoantigen Selection Alliance (TESLA) Point of View PICI Catalyzes Scientific Innovation Cancer Research Heroes An Insider View of PICI’s Pancreatic Clinical Trial PRINCE Cancer Research Heroes PICI Takes On Prostate Cancer: A Q&A with the Experts Research Project TRIBUTE Cancer Research Heroes A Visionary Paving the Way for Faster and Better Cancer Cures Announcement Note from PICI’s President and CEO Jeff Bluestone: Introducing Our New Brand Clinical Trial The PORTER Trial